Ankur joined Abingworth in October 2024 and works with our transatlantic investment team, with particular focus on Clinical Co-Development, evaluating new investment opportunities and supporting existing investments.
Before his move to Abingworth, Ankur was a Senior Associate at NovaQuest Capital Management, responsible for financial modeling and due diligence of both Phase 3 structured finance and commercial-stage royalty monetization deals. Previously, Ankur worked as Manager of Corporate Development at Boston Pharmaceuticals supporting the in-licensing of early-stage assets across all therapeutic areas. Prior to that, Ankur was a Senior Associate at Artisan Healthcare Consulting, where he worked on corporate and commercial strategy projects for biopharmaceutical companies.
Ankur holds a BS in Biomedical Engineering from the University of Connecticut.
